PrimeRFP SCOUT · Federal Contract Profile

Jazz Pharmaceuticals (H9AXCNRA5NE6)Federal contracts · 3 recompetes

Jazz Pharmaceuticals holds $4.5M in federal volume across 57 award actions, with 100% at Department of Veterans Affairs (VA). SCOUT tracks 3 incumbent recompetes — an estimated $906K returning to market over the next 24 months (Moderate exposure). Primary work: Pharmaceutical Preparation (100% prime). Obligations are down 9% year over year.

$4.5M

Federal Volume

Recompetes (24mo)

Top Agency · 100% firm-wide

57

Award Actions

Choose one — this changes what we ask next

Score my firm against Jazz Pharmaceuticals

Email me when a Jazz Pharmaceuticals recompete window opens.

Data through August 2026 · refreshed monthly · window Aug 2025 – Aug 2026

What they do

Capability

Service lines

PHARMACEUTICAL PREPARATION MANUFACTURING

Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS

Where they win

Sole agency

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$4.5M · 100% of firm total

Recompete exposure: Moderate · 3 in 24mo

Jazz Pharmaceuticals has an estimated $906K in contracts returning to market over the next 24 months.

Who buys from them

Agency buyer map

1 buyers

Department of Veterans Affairs (VA)114 awards · repeat buyer · $4.5M

Recompete exposure & trajectory

Recompete exposure

Moderate

Jazz Pharmaceuticals has an estimated $906K in contracts returning to market over the next 24 months. 3 within 6 months ($906K).

XYWAV 500MG/ML ORAL SOLUTION, AND XYREM 500MG/ML ORAL SOLUTION →

PIID: 36C26026F0027 · Expires 2026-09-30

$456K

PHARM - XYWAV →

PIID: 36C26026F0013 · Expires 2026-09-30

$240K

PHARM - XYREM →

PIID: 36C26026F0012 · Expires 2026-09-30

$210K

Trajectory

▼ Consolidating-9% YoYFY2025 vs FY2024

'24

'25

“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”

— Gwyne Taylor, Tailored Global

Explore another company

Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Jazz Pharmaceuticals hold?

Jazz Pharmaceuticals (UEI H9AXCNRA5NE6) shows $4.5M across 57 award actions in SCOUT’s public USASpending-backed profile, with Department of Veterans Affairs (VA) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Jazz Pharmaceuticals have?

Jazz Pharmaceuticals shows $4.5M across 57 award actions. SCOUT tracks 3 incumbent recompetes ($906K) returning to market in the next 24 months.

Which agencies does Jazz Pharmaceuticals work with?

Jazz Pharmaceuticals’s firm-wide obligated mix is led by Department of Veterans Affairs (VA) (100%).

What is the UEI for Jazz Pharmaceuticals?

The Unique Entity ID (UEI) for Jazz Pharmaceuticals is H9AXCNRA5NE6.

Does Jazz Pharmaceuticals have contracts coming up for recompete?

Yes — SCOUT tracks 3 incumbent recompetes in the next 24 months (Moderate exposure). Open the recompete section on this page for PIID-level timing.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.